arrow
S

Samir Zaidi

Yale University
H指数:26
被引数:7,048

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1
2024-10-111
OAAI
Single- cell analysis of treatment- resistant prostate cancer: Implications of cell state changes for cell surface antigen- targeted therapies
2024-07-054
OAAI
Assessment of TROP2, CEACAM5 and DLL3 in metastatic prostate cancer: Expression landscape and molecular correlates
2024-05-173
OAAI
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix
2024-04-161
PRE
Exportin 1 inhibition prevents neuroendocrine transformation through SOX2 down-regulation in lung and prostate cancers
2023-08-0217
PRE
Brain atlas for glycoprotein hormone receptors at single-transcript level
2022-09-0214
OA
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability
CANCER
IF5.1
2021-12-0749
OAAI
A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)
2021-08-0130
OA
Integrated mutational landscape analysis of uterine leiomyosarcomas
2021-04-0568
OA
Histone H2B monoubiquitination regulates heart development via epigenetic control of cilia motility

组蛋白H2B单泛素化通过纤毛运动的表观遗传控制调节心脏发育

2019-06-2433
OAAI
Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency
2017-12-1142
OAAI
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands
2017-10-09606
OAAI
Neurogenetic analysis of childhood disintegrative disorder
2017-04-0418
OAAI
Mutations in the Histone Modifier PRDM6 Are Associated with Isolated Nonsyndromic Patent Ductus Arteriosus (vol 98, pg 1082, 2016)
2016-10-0111
OAAI